Your daily source for trading strategies, tech news, and politically incorrect humor.
Hey there, Bullets Fans –
Your Morning Bullets Brief Updates are here! And that means trivia is, too.
May the Fourth be with you… Do you know the origin of this phrase? When was it first used?
Think you know the answer? You can check it in the closing area down below!
Image Source: NYSE
Stock futures dipped slightly this morning, falling from yesterday’s rally.
Today, officials from Pfizer announced that it would apply for full vaccine approval in this country by month’s end. Should the company receive that approval, Pfizer would then have the ability to market its two-dose drug to consumers. Shares of the company were up 1.5% in the premarket on the news. Shares of CVS Health also shot up this morning after the company reported stellar earnings for the first quarter.
Tuesday also marks the beginning of restrictions for travelers coming from India, as that country navigates a surge in virus cases. There are more than 20 million cases right now.
Other News That Matters To You:
Here is why you don’t want to miss this once-in-a-lifetime opportunity
Image Source: Reuters
A new survey shows that nearly 20% of Americans who have yet to get the vaccine will still opt for the Johnson & Johnson version, even after the blood-clot scare.
According to the latest data, about 17% of Americans say they’d prefer to receive the single-shot drug over either of the other, two-dose options. That number reflects a decrease from the 29% who felt this way back in March, before the blood clot issue.
The Food and Drug Administration and the Centers for Disease Control and Prevention initially recommended pausing the use of the Johnson & Johnson vaccine after some women experienced rare but severe blood clots after their vaccinations. That recommendation was lifted on April 23, after it was determined that the benefits dwarfed the risks.
More Headline You Need To Read: